United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 26, 2026 · Filed May 27, 2026

On May 26, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$572.94 for US$5.73M under a trading plan, leaving 18,876 shares. Filed May 27, 2026 (Form 4).

Sold
10,000 shares
Price
US$572.94 average (US$559.58 to US$578.12)
Value
US$5.73M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 26, 2026Common StockOption exercise10,000US$117.7628,876Direct
May 26, 2026Common StockSale25US$559.5828,851Direct
May 26, 2026Common StockSale135US$561.2128,716Direct
May 26, 2026Common StockSale280US$564.0228,436Direct
May 26, 2026Common StockSale240US$566.3728,196Direct
May 26, 2026Common StockSale520US$567.3627,676Direct
May 26, 2026Common StockSale1,040US$568.5426,636Direct
May 26, 2026Common StockSale760US$569.7925,876Direct
May 26, 2026Common StockSale700US$570.9225,176Direct
May 26, 2026Common StockSale860US$571.9324,316Direct
May 26, 2026Common StockSale440US$572.7023,876Direct
May 26, 2026Common StockSale281US$574.1323,595Direct
May 26, 2026Common StockSale809US$575.2422,786Direct
May 26, 2026Common StockSale1,221US$576.2121,565Direct
May 26, 2026Common StockSale1,929US$577.1319,636Direct
May 26, 2026Common StockSale760US$578.1218,876Direct

Source

View original at SEC

Related